Status:
COMPLETED
US PRECISION Implementation Study
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
13-130 years
Phase:
NA
Brief Summary
The primary objective of this community program intervention study is to assess the process and potential benefits of integrating the AIRQ®, Asthma Checklist, and educational resources (PRECISION prog...
Detailed Description
This community program intervention study will examine the process of integrating the AIRQ, Asthma Checklist, and educational resources (PRECISION program) into clinical practice using either in-perso...
Eligibility Criteria
Inclusion
- \>= 13 years of age at the time of enrollment
- Diagnosis of HCP-confirmed asthma
- Able to read, understand and speak English or Spanish sufficiently self-complete or be administered the AIRQ via telephone, desktop, or mobile device (e.g., smartphone, iPad)
- Provide consent (adults/parents/guardians) and assent (age 13-17 years) to participate in the study.
Exclusion
- Current diagnosis of active COPD or any lower respiratory diagnosis other than asthma
- Has a cognitive impairment, hearing difficulty, acute psychopathology, medical condition, or insufficient knowledge of the English or Spanish language that, in the opinion of the investigator, would interfere with his or her ability to agree to participate and/or complete the AIRQ or other study questionnaires
Key Trial Info
Start Date :
April 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
857 Patients enrolled
Trial Details
Trial ID
NCT04891978
Start Date
April 20 2021
End Date
April 30 2023
Last Update
July 8 2025
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Birmingham, Alabama, United States, 35209
2
Research Site
Leesburg, Florida, United States, 34748
3
Research Site
Honolulu, Hawaii, United States, 96819
4
Research Site
Fort Wayne, Indiana, United States, 46802